chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Post-Herpetic; Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.    On or about 19-APR-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot# and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, shortly after receiving zoster vaccine live (ZOSTAVAX), patient suffered from a painful blistering rash. As a result of these symptoms, patient was seen and treated by medical providers and was diagnosed with shingles and post herpetic neuralgia (reported as post-herpetic). As a direct and proximate result of zoster vaccine live (ZOSTAVAX), patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). Patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of patient's condition. As a result of zoster vaccine live (ZOSTAVAX), patient sustained severe and permanent personal injuries. Further, as a tragic consequence of Company's wrongful conduct, patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Company's conduct, patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of post herpetic neuralgia and herpes zoster was reported as not recovered/not resolved. The reporter considered post herpetic neuralgia and herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).  Shingles and post herpetic neuralgia were considered to be disabling.
Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen). On 09-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) and PRODUCT STORAGE ERROR (Some doses that may have been administered past 30 days from being thawed/The vaccines were applied to patients after being refrozen) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment medication was provided.
pt recv vax 3JAN96 & 27MAY97 pt broke out & devel a fever of 102;pt presented to MD office;
L deltoid swollen, red, warm to touch temp of 99.3 and headache. Pt applied ice, took BENADRYL. To soon
Patient reports having had a rash develop two days after the injection, self-treated with benadryl as directed by urgent care.  Patient states a sore formed in his mouth the next day after the rash had started.
Fever, major aches and pains, tiredness. Had to take multiple naps and aspirin to get through the first day after I received the vaccine. Couldn't go to work. The second day: fever lower, minor aches and pain, had to take one long, deep nap in the afternoon, plus aspirin to get through the rest of the day. Not strong enough to work today either. Third day: symptoms dissipating by end of day. Really not sure I want to go through this again with the second dosage in a couple of months. I felt awful.
she is going into depression and spoke of "hanging myself on a tree"; bone chilling chills; whole body aches; lingering cough; no energy; headache; flu like symptoms; swollen legs; water retention; she is going into depression; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number Unknown) via an unspecified route of administration on 26Mar2021 at single dose for Covid-19 immunization. The patient's medical history included diabetic. The patient's concomitant medications were not reported. The patient previously took first dose of BNT62B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) on 05Mar2021 via an unspecified route of administration as single dose for Covid-19 immunization and experienced bone chilling chills, body ache, lingering cough, no energy, headache, flu like symptoms, swollen leg and water retention. Beginning after the first dose and been going on for over 3 months she reported symptoms of bone chilling chills, body aches, lingering cough, no energy, headache, flu like symptoms, swollen legs, and water retention. Caller was followed by nephrology and endocrinology. Caller saw nephrologist who reported everything was fine from her end. Caller was concerned for a heart condition and saw a cardiologist on Monday because of the swollen legs and water retention who did a chest CT, echocardiogram, and EKG all of which they said were fine. Caller recently saw a "lungs doctor" who prescribed albuterol and Spiriva for her lingering cough. Caller seeking information on how long these symptoms were going to last. Caller reported she has an appointment tomorrow with her primary care doctor. Caller stated that was not a common way to live she was going into depression and spoke of "hanging myself on a tree". She has seen several doctors already and there has been a lot of possibilities and so further cannot pinpoint anything. Caller confirmed she gave this information previously. She was just wondering how long will it take to subside or was this going to be an ongoing thing. She states she can't live like that. There were side effects that she has and she was curious how long was it go to be until they subside. As a treatment for cough patient was prescribed albuterol and Spiriva. The patient underwent lab tests and procedures which included Chest CT, Echocardiogram and (Electrocardiogram) EKG and the result of all was fine. The outcome of event was not recovered at the time of reporting.  Information about lot/batch number is requested follow-up attempts are needed.   Amendment: This follow-up report is being submitted to amend previously reported information: event "she is going into depression and spoke of "hanging myself on a tree"  was added and coded to "Suicidal ideation; seriousness was upgraded to Medically Significant.
Client rec'd covid vaccine at age 17 - EUA is for 18+  Client rec'd 2nd dose on 03/02/2021  - per advice to complete the series if started
Shakings; Chills; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shakings) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced TREMOR (Shakings) and CHILLS (Chills). At the time of the report, TREMOR (Shakings) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications was reported No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Event outcome updated. to resolved.
I have not had a period since the end of 2018. I started spotting on the 2nd brownish tint started getting brighter in color called my obgyn they are sending me for a transvaginal US on Dec 8, 2021
Stiffness, pain and swelling in all joints. Took Celebrex; Next day started coughing and that went into bronchitis. Still have a productive cough.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022 at 10:51 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 02-Apr-2022 at 10:51 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 02-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had received the vaccine dose number as second booster. No concomitant medications were reported. It was reported that a series of an approximately 540 patients had received lot number in past and had an its 30 days of an expiry date. The vaccine was administered up until its manufactured expiry date of 04-Apr-2022 and this lot number was no longer possessed. No treatment medications were reported.
About 5 weeks after my shot my upper right lip started to feel numb. That grew over a week, and then one afternoon the the course of a couple hours my right arms started to tingle. Suddenly my head also tingled and I felt very woozy, as if I would pass out. My husband rushed me to urgent care, afraid I was having a stroke.
Redness and mild soreness at the injection site; Redness and mild soreness at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Mar2021 10:45 (Lot number: EL3247) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Depression" (unspecified if ongoing); "sensitivity to neomycin" (unspecified if ongoing), notes: not an allergy per se. Concomitant medication(s) included: CALCIUM VITAMIN D; ARIPIPRAZOLE; LAMOTRIGINE. The following information was reported: VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PAIN (non-serious) all with onset 02Mar2021 12:00, outcome "not recovered" and all described as "Redness and mild soreness at the injection site". Therapeutic measures were not taken as a result of vaccination site erythema, vaccination site pain.  Additional information: The patient had not received any other vaccines within 4 weeks. The patient had not been diagnosed with COVID-19 prior vaccination and had not been tested for COVID-19 since the vaccination. "BUPOPRION" received within 2 weeks of vaccination.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a nurse practitioner refers to a 19 year old male patient. On 09-JUL-2014, the patient was vaccinaed with GARDASIL (dose, Lot# and route of administration not reported). Since vaccination on 09-JUL-2014, reported as for the past 2 months, the patient has been experiencing welts on his face on and off. The severity of the welts fluctuated for unspecified time periods. The patient sought medical attention by visiting the emergency room as a result of welts being so bad. The patient was not admitted to the hospital. The outcome of welts on face was reported as not recovered. Relatedness between welts on face and therapy with GARDASIL was not provided. Additional information has been requested.
9:30/A Pt. felt faint and was placed back in a chair as she had begun to leave clinic.  BP 78/58 et 15 mins later 9:50/A 100/60 (client had not eaten prior to clinic).  She was given juice, fanned et placed a cold cloth on her neck, upper back.  Left clinic at 10AM in good condition.  Mom instructed to observe et get her something to eat immediately.  Also to eat prior to attending next clinic.
Migraines; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraines) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraines). At the time of the report, MIGRAINE (Migraines) had not resolved.            No concomitant medication was provided by the reporter  No treatment medication was provided by the reporter.  Patient has migraines everyday since receiving the booster
Pt started feeling lightheaded and tremors. States last she ate or drank anything was as 6:00am in the morning. States symptoms lasted about 10 min.
14JUN91 pt recvd immun & felt hot & weak, diaphoresing, did not fall or faint; Felt better in 2-3min; Left clinic p/35min given flds & foods; 1005AM p100, BP 110/80; 1010AM p80; 1020AM p78, BP 110/78; 1035AM p72, BP 110/78;
patient died of complications of pneumonia related to COVID-19; patient died of complications of pneumonia related to COVID-19; This is a spontaneous report from a contactable consumer.  A 92-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 06Jan2021 at 13:00 (at the age of 92-years-old) as a single dose for COVID-19 immunization.  Medical history included melanoma, chronic obstructive pulmonary disease, diabetes mellitus, and diminished kidney function; all from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient was taking unspecified concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was vaccinated on 06Jan2021 during an existing hospitalization. On 22Jan2021, the patient developed pneumonia related to COVID-19. The patient did not receive any treatment. On 03Feb2021, the patient died of complications of pneumonia related to COVID-19. It was not reported if an autopsy was performed. The events were serious for hospitalization prolongation, being life-threatening and death.       The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Reported Cause(s) of Death: patient died of complications of pneumonia related to COVID-19
pt with abscess type lesion on mid abdomen and right axilla.+ yellow exudate, erythema and induration.
Vaccination to right deltoid; 7 days later developed diminished grip strength in right hand, right thoracolumbar muscle spasm with tingling radiculopathy to right hand and leg
slight headache almost immediately after injection that dissipated within 2 hours.  Next morning, 10/22/2022, i felt fatigued, tired, and some leg and body trunk aches in lower back.  No other symptoms evident.
Patient was seen on 11/15/16 and 11/16/16 for Gastroenteritis and vomiting. Patient had normal pyloric ultrasound on 11/16/16. Illness was resolved by 12/8/16 well child and shot appointment. Received all listed vaccine on 12/8/16. Returned to clinic on 12/15/16 for vomiting and rectal bleeding. Sent for abdominal US which revealed intussusception. Patient sent to hospital ER where surgery was performed.
got so sick; felt exhausted; feeling horrible; health rapidly deteriorated; cannot eat; woke up every single day with her hands and muscles clenched; in excruciating pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 13-Jul-2021 and was forwarded to Moderna on 13-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling horrible), GENERAL PHYSICAL HEALTH DETERIORATION (health rapidly deteriorated), FEEDING DISORDER (cannot eat), MUSCLE TIGHTNESS (woke up every single day with her hands and muscles clenched) and PAIN (in excruciating pain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced FEELING ABNORMAL (feeling horrible), GENERAL PHYSICAL HEALTH DETERIORATION (health rapidly deteriorated), FEEDING DISORDER (cannot eat), MUSCLE TIGHTNESS (woke up every single day with her hands and muscles clenched), PAIN (in excruciating pain) and FATIGUE (felt exhausted). On an unknown date, the patient experienced ILLNESS (got so sick). At the time of the report, FEELING ABNORMAL (feeling horrible), GENERAL PHYSICAL HEALTH DETERIORATION (health rapidly deteriorated), FEEDING DISORDER (cannot eat), MUSCLE TIGHTNESS (woke up every single day with her hands and muscles clenched), PAIN (in excruciating pain) and FATIGUE (felt exhausted) outcome was unknown.            Lab data included blood work and result was normal and also included weight decreased on Apr-2021 No relevant concomitant medications were reported. No treatment Information provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Follow up document received on 24-JUL-2021 and included event  illness was added.
8 hours after I got my vaccine I started feeling cold, chills, headache. I got fever 100.9, fatigue I slept for almost 14 hours in a row. Today, three days after the vaccine I'm not feeling better. the only thing that it's gone is the fever. but I'm still with same symptoms.
unbearable joint pain in every joint, headache, hurt to touch skin. lasted about 30 hours. joint pain continues but isn't as severe after the 30 hours.
With lots of adverse reactions; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (With lots of adverse reactions) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (With lots of adverse reactions). At the time of the report, VACCINATION COMPLICATION (With lots of adverse reactions) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.  The patient was a PSW (Personal Support Workers) at nursing home. The patient was administered with Moderna COVID vaccine last January to February 2 doses.   This case was linked to MOD-2021-344288 (Patient Link).
Pt recv vax on 2/1/99; on same day pt exp raised rash at both vax sites
It was discovered that Varicella was given instead of Proquad, mom declined MMR vaccine.
Patient given monovalent dose after date of authorization. Authorization expiration  date was 8/31/22. Provider unaware of expiration date at the time of administration. Notified of expiration date on 9/14/22, at which time the Department of Health directed the provider to complete an event report. Shipment of bivalent booster doses were not received until 9/12/22.
PCV13 vaccine given in office IM into left arm on 03/28/11. Mother reports redness, warm and soreness starting a "few hours after vaccine was given". Seen in office 03/30/11 with continued localized redness. Patient was treated with KEFLEX and BENADRYL.
positive HCG; No other reactions or events, Vaccine site in appropiate healing stage without any complications
Pt developed 13cm x 15cm area of swelling and mottled rash on left anterior thigh within 24 hours after receiving DTaP and IPV in that thigh, just above area of swelling.
Injection site swollen, tender, warm 4 x 4.5 inches, fever 101.1, H/A.
Called by hospital and informed that child hospitalized in ICU for transverse myelitis on 6/17/03 following immunization on 6/16/03. The 60 day follow up received on 9/17/03 states not completely but greatly improved. Walking with walker now. R hand still with decreased function, needs splint. Gets catheterization q 9 hrs for urination, wears diaper. Tracheostomy removed. Will be discharged this week.
Subsequent to receiving first and second doses of varicella virus vaccine live a serum varicella zoster virus antibody test revealed a lack of seroconversion. The pt sought unspecified medical attention.
Mom reports that child has been feeling ill since vaccines. On 8/21/10 mom noted rash on trunk spread to face. Mom stated her sibling had same experience with MMR in past. We encouraged to stay home from school & see her physician for Dx. She will call MD.
This case meets criteria for vaccine breakthrough review.  Was positive at hospital, now admitted. Sx include hypoxia, fall, fever.
Hives, global pruritis, burning mouth, diarrhea abdominal pain all of acute onset. Pt given PO BENADRYL and IM epinephrine in office. Medic transport to ER where given albuterol, famotidine, prednisone, IV fluids.
Received the shot 1.29.21 and on 2.13.21 noticed something was wrong and by 2.15.21 my arms and left leg had no strength. My left leg would not hold me up. Went to the ER.